Krsnaa Diagnostics Board Approves ₹120 Crore Asset Sale

Date: September 28, 2026

Board of Directors approved sale of identified diagnostic equipment for aggregate consideration of up to ₹120 crore to identified purchaser(s)
Meeting held on September 28, 2026, commenced at 14:00 hrs IST and concluded at 18:30 hrs IST
Board authorized Operations Committee to finalize terms and conditions and undertake necessary formalities within approved ₹120 crore limit

Nature of transaction: Sale of identified diagnostic equipment
Consideration: Up to ₹120 crore aggregate
Assets comprise identified freehold assets not subject to any security interest created in favor of lenders
Strategic rationale: Part of ongoing initiative to optimize asset portfolio and enhance capital efficiency
Expected benefits: Unlock value from assets, facilitate efficient capital recycling towards core diagnostic business and growth opportunities, improve asset utilization, enhance return on capital employed (ROCE), strengthen balance sheet
Transaction not driven by impairment or diminution in asset value
No material adverse impact on profit and loss account or ongoing business operations expected
Does not constitute sale of undertaking under Section 180(1)(a) of Companies Act, 2013